Bonaventure Equity Psychedelic Investment & Policy Summit
Thursday, November 17, 2022
5:30pm -7:30pm
October 19, 2022 - Bonaventure Equity, LLC (“BVE”) is pleased to be hosting the Psychedelic Investment & Policy Summit West, in Manhattan Beach on November 17th. Focusing on the role regulations, research and investment will play in shaping new treatments and healthcare disruptions, the keynote panel features experts leading research, investment, FDA policy and veterans perspectives as psychedelics are emerging as viable treatment for significant medical needs.
Nick Norris, (@nick_norris1981) is a graduate of both the United States Naval Academy and Basic Underwater Demolition / SEAL (BUD/S) Class 247. Upon completion of SEAL training in 2004, Nick assumed progressively higher positions of leadership within Naval Special Warfare. His deployed roles included combat advisor to Iraqi and Afghan military units, Cross Functional Team Leader, and Ground Force Commander during combat operation in both Iraq and Afghanistan.
Nick was most recently assigned to Naval Special Warfare Basic Training Command — SEAL Qualification Training (SQT) as Officer in Charge prior to transitioning off Active Duty. Originally from Chicago, Nick received his Bachelor in Science from the United States Naval Academy in 2003 and his Masters of Science in Real Estate from The University of San Diego in 2013. He is a Board Member of Veterans Exploring Treatment Solutions, a non profit focused on ending the veteran suicide epidemic via resources, research, and advocacy related to psychedelic assisted therapy. Nick is also the Co-Founder and CEO of Protekt Products, a wellness company that is committed to positively impacting customer health via both personal care products and nutritional supplements. Both Protekt and VETS value the power of time spent in the outdoors and the positive impact it has on overall well-being.
Michal Werner, Partner at Holland & Knight and leads their regulatory affairs and FDA practice in DC.
Adam Halberstadt, Associate Professor and Founding Member UC San Diego Psychedelics and Health Research Initiative.